MAPT and Alzheimer disease: For example, intranasal DFO treatment in mouse models of AD improved memory performance in spatial mazes and reduced pathological hallmarks, including brain Aβ levels and tau hyperphosphorylation (Fine et al., 2024; Fine et al., 2012; Fine et al., 2015; Fine et al., 2017; Guo et al., 2013b).